Neurofeedback for Autistic Spectrum Disorder: A Review of the Literature

[1]  James R. Evans,et al.  Introduction to Quantitative EEG and Neurofeedback , 2011 .

[2]  Robert Coben,et al.  The Relative Efficacy of Connectivity Guided and Symptom Based EEG Biofeedback for Autistic Disorders , 2010, Applied psychophysiology and biofeedback.

[3]  J. Buitelaar,et al.  Long-term effects of neurofeedback treatment in autism , 2009 .

[4]  Robert Coben,et al.  Connectivity Theory of Autism: Use of Connectivity Measures in Assessing and Treating Autistic Disorders , 2008 .

[5]  C. Riccio.  Autism Diagnostic Interview—Revised , 2008 .

[6]  J. Pineda,et al.  Positive behavioral and electrophysiological changes following neurofeedback training in children with autism , 2008 .

[7]  Kai-fun Yu,et al.  Reduced Bone Cortical Thickness in Boys with Autism or Autism Spectrum Disorder , 2008, Journal of autism and developmental disorders.

[8]  S. J. James,et al.  The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study , 2007, BMC pediatrics.

[9]  Robert D Gibbons,et al.  3-year follow-up of the NIMH MTA study. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[10]  Robert Coben,et al.  Assessment-Guided Neurofeedback for Autistic Spectrum Disorder , 2007 .

[11]  J. Ducharme,et al.  Errorless Compliance Training , 2007, Behavior modification.

[12]  Svein Eikeseth,et al.  Outcome for Children with Autism who Began Intensive Behavioral Treatment Between Ages 4 and 7 , 2007, Behavior modification.

[13]  D. Zachor,et al.  The effects of intellectual functioning and autism severity on outcome of early behavioral intervention for children with autism. , 2007, Research in developmental disabilities.

[14]  D. Hammond,et al.  What Is Neurofeedback , 2007 .

[15]  C. Klier,et al.  Omega-3 Fatty Acids Supplementation in Children with Autism: A Double-blind Randomized, Placebo-controlled Pilot Study , 2007, Biological Psychiatry.

[16]  Caroline C Brown,et al.  Disordered connectivity in the autistic brain: challenges for the "new psychophysiology". , 2007, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[17]  M. Aref-Adib,et al.  Risperidone for autism spectrum disorder. , 2007, The Cochrane database of systematic reviews.

[18]  E. Butter,et al.  EIGHT CASE REPORTS OF LEARNING RECOVERY IN CHILDREN WITH PERVASIVE DEVELOPMENTAL DISORDERS AFTER EARLY INTERVENTION , 2006 .

[19]  K. Williams,et al.  Chelation therapy and autism , 2006, BMJ : British Medical Journal.

[20]  D. Theriaque,et al.  The Gluten-Free, Casein-Free Diet In Autism: Results of A Preliminary Double Blind Clinical Trial , 2006, Journal of autism and developmental disorders.

[21]  Tobias Egner,et al.  Neurofeedback treatment of epilepsy: from basic rationale to practical application , 2006, Expert review of neurotherapeutics.

[22]  D. Murphy,et al.  Neural Correlates of Executive Function in Autistic Spectrum Disorders , 2006, Biological Psychiatry.

[23]  J. Buitelaar,et al.  Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[24]  Glen O Sallows,et al.  Intensive behavioral treatment for children with autism: four-year outcome and predictors. , 2005, American journal of mental retardation : AJMR.

[25]  C. McDougle,et al.  Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. , 2005, Archives of general psychiatry.

[26]  K. Stoller.  Quantification of Neurocognitive Changes Before, During, and After Hyperbaric Oxygen Therapy in a Case of Fetal Alcohol Syndrome , 2005, Pediatrics.

[27]  Joseph P. McCleery,et al.  EEG evidence for mirror neuron dysfunction in autism spectrum disorders. , 2005, Brain research. Cognitive brain research.

[28]  B. Scolnick.  Effects of electroencephalogram biofeedback with Asperger's syndrome , 2005, International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.

[29]  Vincent J Monastra,et al.  Electroencephalographic Biofeedback in the Treatment of Attention-Deficit/Hyperactivity Disorder , 2005, Applied psychophysiology and biofeedback.

[30]  M. Fitzpatrick.  Evidence of Harm. Mercury in Vaccines and the Autism Epidemic: Medical Controversy , 2005, BMJ : British Medical Journal.

[31]  E. Bullmore,et al.  Functional disconnectivity of the medial temporal lobe in Asperger’s syndrome , 2005, Biological Psychiatry.

[32]  Stephen J. Guter,et al.  An open-label trial of escitalopram in pervasive developmental disorders. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[33]  T. Nakayama,et al.  A Preliminary Study of Methylcobalamin Therapy in Autism , 2005 .

[34]  E. Hollander,et al.  A Placebo Controlled Crossover Trial of Liquid Fluoxetine on Repetitive Behaviors in Childhood and Adolescent Autism , 2005, Neuropsychopharmacology.

[35]  J. Carmen,et al.  Passive Infrared Hemoencephalography: Four Years and 100 Migraines , 2005 .

[36]  Hershel Toomim,et al.  Intentional Increase of Cerebral Blood Oxygenation Using Hemoencephalography (HEG): An Efficient Brain Exercise Therapy , 2005 .

[37]  J. Démos.  Getting Started with Neurofeedback , 2005 .

[38]  J. Suckling,et al.  Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. , 2004, Brain : a journal of neurology.

[39]  Mark F Blaxill,et al.  What's Going on? The Question of Time Trends in Autism , 2004, Public health reports.

[40]  R. Adolphs,et al.  Neuroanatomical substrates of social cognition dysfunction in autism. , 2004, Mental retardation and developmental disabilities research reviews.

[41]  C. McDougle,et al.  Aripiprazole for maladaptive behavior in pervasive developmental disorders. , 2004, Journal of child and adolescent psychopharmacology.

[42]  J. E. Carr,et al.  Secretin as a Treatment for Autism: A Review of the Evidence , 2004, Journal of autism and developmental disorders.

[43]  J. Couper.  Who should pay for intensive behavioural intervention in autism? A parent's view , 2004, Journal of paediatrics and child health.

[44]  M. Just,et al.  Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity. , 2004, Brain : a journal of neurology.

[45]  Robert L. Jones,et al.  Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry. , 2004, Pediatrics.

[46]  Maggie B. Covington.  Omega-3 fatty acids. , 2004, American family physician.

[47]  E. Hill.  Executive dysfunction in autism , 2004, Trends in Cognitive Sciences.

[48]  L. Thompson,et al.  The Neurofeedback Book: An Introduction to Basic Concepts in Applied Psychophysiology , 2003 .

[49]  Robert L Davis,et al.  Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. , 2003, Pediatrics.

[50]  M. Lauritsen,et al.  Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. , 2003, Pediatrics.

[51]  Chantal Sicile-Kira,et al.  Autism spectrum disorders : the complete guide to understanding autism, Asperger's syndrome, pervasive developmental disorder, and other ASDs , 2003 .

[52]  M. Monuteaux,et al.  Use of Citalopram in Pervasive Developmental Disorders , 2003, Journal of developmental and behavioral pediatrics : JDBP.

[53]  Werner Lutzenberger,et al.  Neurofeedback Treatment for Attention-Deficit/Hyperactivity Disorder in Children: A Comparison with Methylphenidate , 2003, Applied psychophysiology and biofeedback.

[54]  Andrés Martin,et al.  Low-Dose Fluvoxamine Treatment of Children and Adolescents with Pervasive Developmental Disorders: A Prospective, Open-Label Study , 2003, Journal of autism and developmental disorders.

[55]  Vincent J Monastra,et al.  The Effects of Stimulant Therapy, EEG Biofeedback, and Parenting Style on the Primary Symptoms of Attention-Deficit/Hyperactivity Disorder , 2002, Applied psychophysiology and biofeedback.

[56]  J. Rohrbaugh,et al.  Beta power in the EEG of alcoholics , 2002, Biological Psychiatry.

[57]  C. Ritch,et al.  Fluoxetine response in children with autistic spectrum disorders: correlation with familial major affective disorder and intellectual achievement , 2002, Developmental medicine and child neurology.

[58]  Betty Jarusiewicz,et al.  Efficacy of Neurofeedback for Children in the Autistic Spectrum: A Pilot Study , 2002 .

[59]  P. Lehrer,et al.  Template for Developing Guidelines for the Evaluation of the Clinical Efficacy of Psychophysiological Interventions , 2002, Applied psychophysiology and biofeedback.

[60]  Jaquelyn B. McCandless,et al.  Children with Starving Brains: A Medical Treatment Guide for Autism Spectrum Disorder , 2002 .

[61]  P. Wainwright.  Dietary essential fatty acids and brain function: a developmental perspective on mechanisms , 2002, Proceedings of the Nutrition Society.

[62]  A. Young,et al.  A systematic review of the use of atypical antipsychotics in autism , 2002, Journal of psychopharmacology.

[63]  C. Golden,et al.  IMPROVEMENT IN CEREBRAL METABOLISM IN CHRONIC BRAIN INJURY AFTER HYPERBARIC OXYGEN THERAPY , 2002, The International journal of neuroscience.

[64]  K. Reichelt,et al.  A Randomised, Controlled Study of Dietary Intervention in Autistic Syndromes , 2002, Nutritional neuroscience.

[65]  Tristram H. Smith,et al.  Intensive Behavioral Treatment at School for 4- to 7-Year-Old Children with Autism , 2002, Behavior modification.

[66]  Andrew E. Skodol,et al.  DSM-IV-TR Casebook: A Learning Companion to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision , 2001 .

[67]  C. Barthélémy,et al.  Plasma fatty acid levels in autistic children. , 2001, Prostaglandins, leukotrienes, and essential fatty acids.

[68]  R. Tamura,et al.  Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[69]  A. Griffiths,et al.  Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial. , 2001, Pediatrics.

[70]  A. Sandler,et al.  Committee on Children With Disabilities The Pediatrician ’ s Role in the Diagnosis and Management of Autistic Spectrum Disorder in Children , 2001 .

[71]  J B Poline,et al.  Temporal lobe dysfunction in childhood autism: a PET study. Positron emission tomography. , 2000, The American journal of psychiatry.

[72]  T. Uema,et al.  Abnormal regional cerebral blood flow in childhood autism. , 2000, Brain : a journal of neurology.

[73]  A. Kazanjian,et al.  Autism and Lovaas treatment: a systematic review of effectiveness evidence. , 2000, International journal of technology assessment in health care.

[74]  J. G. Bell,et al.  Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders? , 2000, Prostaglandins, leukotrienes, and essential fatty acids.

[75]  B. Rimland.  Secretin treatment for autism. , 2000, New England Journal of Medicine.

[76]  M. Fregly,et al.  Autism and Schizophrenia: Intestinal Disorders , 2000, Nutritional neuroscience.

[77]  J. Bodfish,et al.  Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. , 1999, The New England journal of medicine.

[78]  F. Volkmar,et al.  Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[79]  E. John,et al.  Conventional and quantitative electroencephalography in psychiatry. , 1999, The Journal of neuropsychiatry and clinical neurosciences.

[80]  N. Bayley.  Bayley Scales of Infant Development , 1999 .

[81]  James Robert Brašić,et al.  Aspergers Syndrome: A Guide for Parents and Professionals , 1999, Neurology.

[82]  C. McDougle,et al.  Paroxetine in autism. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[83]  M. Viti,et al.  The gluten-free diet: a nutritional risk factor for adolescents with celiac disease? , 1998, Journal of pediatric gastroenterology and nutrition.

[84]  D. Skuse.  Asperger's Syndrome: A Guide for Parents and Professionals , 1998 .

[85]  S. Ozonoff,et al.  Effectiveness of a Home Program Intervention for Young Children with Autism , 1998, Journal of autism and developmental disorders.

[86]  C. McDougle,et al.  Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation. , 1998, Journal of clinical psychopharmacology.

[87]  S. Sheinkopf,et al.  Home-Based Behavioral Treatment of Young Children with Autism , 1998, Journal of autism and developmental disorders.

[88]  C. McDougle,et al.  A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. , 1996, Archives of general psychiatry.

[89]  Michael Linden,et al.  A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities , 1996, Biofeedback and self-regulation.

[90]  J. Hellings,et al.  Sertraline response in adults with mental retardation and autistic disorder. , 1996, The Journal of clinical psychiatry.

[91]  J. Ducharme.  Errorless Compliance Training , 1996, Behavior modification.

[92]  P. Adeleine,et al.  Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. , 1995, Stroke.

[93]  J. Mountz,et al.  Functional deficits in autistic disorder: characterization by technetium-99m-HMPAO and SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[94]  D. Goldstein,et al.  Positive Outcome with Neurofeedback Treatment in a Case of Mild Autism , 1995 .

[95]  C. McDougle,et al.  A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. , 1995, The American journal of psychiatry.

[96]  J. Lubar,et al.  Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in T.O.V.A. scores, behavioral ratings, and WISC-R performance , 1995, Biofeedback and self-regulation.

[97]  R. Snead,et al.  Paroxetine for self-injurious behavior. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[98]  J. Birnbrauer,et al.  The Murdoch Early Intervention Program After 2 Years , 1993, Behaviour Change.

[99]  M. Tansey,et al.  Ten-year stability of EEG biofeedback results for a hyperactive boy who failed fourth grade perceptually impaired class , 1993, Biofeedback and self-regulation.

[100]  B. Leventhal,et al.  Fluoxetine treatment of children and adults with autistic disorder and mental retardation. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[101]  K Kouris,et al.  Cerebral Blood Flow Abnormalities in Adults with Infantile Autism , 1992, The Journal of nervous and mental disease.

[102]  S. Harris,et al.  Changes in cognitive and Language functioning of Preschool children with autism , 1991, Journal of autism and developmental disorders.

[103]  E. Schopler,et al.  Relation of behavioral treatment to "normal functioning": comment on Lovaas. , 1989, Journal of consulting and clinical psychology.

[104]  K. Radack,et al.  Omega-3 Fatty Acids , 2021, Encyclopedia of Evolutionary Psychological Science.

[105]  Stephen R. Anderson,et al.  Intensive home-based early intervention with autistic children. , 1987 .

[106]  Mark S. Schwartz,et al.  Biofeedback: A Practitioner's Guide , 1987 .

[107]  O. I. Lovaas,et al.  Behavioral treatment and normal educational and intellectual functioning in young autistic children. , 1987, Journal of consulting and clinical psychology.

[108]  M. Aman,et al.  The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. , 1985, American journal of mental deficiency.

[109]  E. Schopler,et al.  Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS) , 1980, Journal of autism and developmental disorders.

[110]  J. Lubar,et al.  Behavioral management of epileptic seizures following EEG biofeedback training of the sensorimotor rhythm , 1976, Biofeedback and self-regulation.

[111]  J Q Simmons,et al.  Some generalization and follow-up measures on autistic children in behavior therapy. , 1973, Journal of applied behavior analysis.

[112]  M B Sterman,et al.  Suppression of seizures in an epileptic following sensorimotor EEG feedback training. , 1972, Electroencephalography and clinical neurophysiology.

[113]  H. S. Davis,et al.  A Controlled Study , 1966 .

[114]  Marco Congedo,et al.  Neurofeedback Improves Executive Functioning in Children with Autism Spectrum Disorders. , 2009 .

[115]  W. Hills,et al.  A Comparison of QEEG Characteristics in Pediatric Asperger ' s Syndrome and Attention Deficit Disorder , 2008 .

[116]  Carolyn B. Yucha,et al.  Evidence-based practice in biofeedback and neurofeedback , 2008 .

[117]  Margaret Strock,et al.  Autism Spectrum Disorders (Pervasive Developmental Disorders). , 2007 .

[118]  D. Rossignol,et al.  Hyperbaric oxygen therapy may improve symptoms in autistic children. , 2006, Medical hypotheses.

[119]  Jeff Sigafoos,et al.  Internet survey of treatments used by parents of children with autism. , 2006, Research in developmental disabilities.

[120]  S. Santangelo,et al.  What is known about autism: genes, brain, and behavior. , 2005, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[121]  C. McDougle,et al.  Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. , 2005, The American journal of psychiatry.

[122]  Susan L. Santangelo,et al.  What is Known About Autism , 2005 .

[123]  W. McGinnis,et al.  Autism: A Unique Type of Mercury Poisoning , 2004 .

[124]  Mark R. Geier,et al.  A Case-Control Study of Mercury Burden in Children with Autistic Spectrum Disorders , 2003 .

[125]  R. Nicolson,et al.  A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders. , 2002, Journal of child and adolescent psychopharmacology.

[126]  J. Herbert,et al.  SEPARATING FACT FROM FICTION IN THE ETIOLOGY AND TREATMENT OF AUTISM A Scientific Review of the Evidence , 2002 .

[127]  M. McCormick,et al.  Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders , 2001 .

[128]  M. Kosorok,et al.  Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. , 2001, Pediatrics.

[129]  P. Muglia,et al.  Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation. , 2000, Journal of child and adolescent psychopharmacology.

[130]  C. McDougle,et al.  Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors. , 2000, Journal of autism and developmental disorders.

[131]  J. Piven,et al.  SPECT findings in mentally retarded autistic individuals. , 2000, The Journal of neuropsychiatry and clinical neurosciences.

[132]  S. Hughes,et al.  Autistic Spectrum Disorder in Children , 2000 .

[133]  Tristram H. Smith,et al.  Randomized trial of intensive early intervention for children with pervasive developmental disorder. , 2000, American journal of mental retardation : AJMR.

[134]  V. Lacroix,et al.  Effects of hyperbaric oxygen therapy on children with spastic diplegic cerebral palsy: a pilot project. , 1999, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[135]  H. Jasper,et al.  The ten-twenty electrode system of the International Federation. The International Federation of Clinical Neurophysiology. , 1999, Electroencephalography and clinical neurophysiology. Supplement.

[136]  Rima E. Laibow.  Medical Applications of NeuroBioFeedback , 1999 .

[137]  L. Nabors,et al.  Improved social and language skills after secretin administration in patients with autistic spectrum disorders. , 1998, Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians.

[138]  D. DeMaso,et al.  Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. , 1997, Journal of child and adolescent psychopharmacology.

[139]  B. Siegel-Gorelick.  The World of the autistic child : understanding and treating autistic spectrum disorders , 1996 .

[140]  Joel F. Lubar,et al.  Neurofeedback for the management of attention-deficit/hyperactivity disorders. , 1995 .

[141]  R. Teodorescu.  [Behavioral management]. , 1993, Soins Psychiatrie.

[142]  P. Mundy,et al.  Normal versus High-Functioning Status in Children with Autism. , 1993 .

[143]  E. Schopler,et al.  Individualized assessment and treatment for autistic and developmentally disabled children , 1990 .

[144]  P. J. Krantz,et al.  Age at intervention and treatment outcome for autistic children in a comprehensive intervention program , 1985 .

[145]  E. Schopler,et al.  Parents as cotherapists in the treatment of psychotic children , 1971, Journal of autism and childhood schizophrenia.

[146]  Johnj Mceachln,et al.  Long-term Outcome for Children with Autism Who Received Early Intensive Behavioral Treatment , 2022 .